MDClone, a Beer-Sheva, Israel-based data platform for the entire healthcare ecosystem, closed a $26m Series B funding.
The round was led by aMoon, with participation from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners.
The company intends to use the funds to further develop its existing platform and build new products and novel approaches leveraging data across its global network, as well as accelerate sales and marketing efforts.
Led by Ziv Ofek, Founder & CEO, MDClone has a data platform for the entire healthcare ecosystem, enabling on-demand and self-service access to healthcare data without IT mediators and, using synthetic data, without risk to patient privacy.
At the core of its platform is a healthcare-oriented data lake and discovery tool which, together with MDClone’s patented Synthetic Data Engine, provides a rapid self-service environment for caregivers and researchers to understand any element of the care path for any population of interest. This innovation aims to add speed to data and insights, while fully protecting patient privacy.
Founded in 2016 in Israel, the company has since expanded to the U.S. where its current clients include Washington University School of Medicine in St. Louis, Intermountain Healthcare and the Regenstrief Institute. Israeli clients include Rambam Health Care Campus, Sheba Medical Center, Tel-Aviv Sourasky Medical Center, Maccabi Healthcare Services, Clalit Healthcare Services, and Assuta Medical Center.